Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions-Reference-Cited by-同舟云学术

Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions

Published:2015-01 Issue:2 Volume:356 Page:404-409
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Jin,Paris Pamela L.,Chen Jinyun,Ngo Vy,Yao Hui,Frazier Marsha L.,Killary Ann M.,Liu Chang-Gong,Liang Han,Mathy Christian,Bondada Sandhya,Kirkwood Kimberly,Sen Subrata

Funder

Early Detection Research Network of the National Institutes of Health, National Cancer Institute

NIH

Patient Gift Funds

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin,2014

2. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients;Yeo;Ann. Surg,1995

3. MicroRNA dissects out dangerous pancreatic cysts from all the rest;Thomas;Clin. Cancer Res,2012

4. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas;Tanaka;Pancreatology,2012

5. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts;Matthaei;Clin. Cancer Res,2012

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease;BMC Cancer;2024-08-06

2. Circular RNA LIPH promotes pancreatic cancer glycolysis and progression through sponge miR‐769‐3p and interaction with GOLM1;Clinical and Translational Medicine;2024-08

3. Molecular Mechanisms and Clinical Implications of Noncoding RNAs in Cancer;Non-Coding RNA;2024-06-25

4. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine;Non-Coding RNA;2024-02-21

5. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease;2023-11-01